The precise identification of ubiquitination sites is crucial for understanding cellular regulation, disease mechanisms, and developing targeted therapies.
The ubiquitin-proteasome system (UPS) is a critical regulator of oncogenesis, yet the study of low-abundance ubiquitinated proteins presents significant technical challenges.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing protocols for the enrichment of ubiquitinated proteins from complex tissue samples.
This article provides a comprehensive guide for researchers and drug development professionals seeking to minimize background noise in ubiquitylomics datasets.
This article explores the critical intersection of single-cell analysis and ubiquitination states in dissecting tumor heterogeneity, a central challenge in oncology.
This article provides a comprehensive resource for researchers and drug development professionals on the application of ubiquitination-specific antibodies in cancer immunohistochemistry (IHC).
Deubiquitinating enzymes (DUBs) have emerged as a promising therapeutic target class in oncology, with over 100 proteases regulating key cancer-associated proteins.
This article provides a comprehensive overview of how mass spectrometry-based proteomics is revolutionizing our understanding of protein ubiquitination in cancer.
This article provides a comprehensive guide for researchers and drug development professionals on assessing E3 ubiquitin ligase activity in clinical specimens.
This article explores the critical and dualistic role of the ubiquitin-proteasome system (UPS) in the DNA damage response (DDR) and cancer pathogenesis.